Free Trial

Inogen (INGN) Expected to Announce Quarterly Earnings on Tuesday

Inogen logo with Medical background

Inogen (NASDAQ:INGN - Get Free Report) is projected to release its earnings data after the market closes on Tuesday, February 25th. Analysts expect Inogen to post earnings of ($0.56) per share and revenue of $73.90 million for the quarter. Parties interested in registering for the company's conference call can do so using this link.

Inogen Price Performance

NASDAQ INGN traded down $0.37 during trading hours on Friday, hitting $9.91. 317,365 shares of the company's stock traded hands, compared to its average volume of 264,570. The company has a market capitalization of $236.06 million, a PE ratio of -4.40 and a beta of 1.02. Inogen has a 52-week low of $5.82 and a 52-week high of $13.33. The firm's 50-day moving average is $10.17 and its 200-day moving average is $10.28.

Wall Street Analysts Forecast Growth

Several research firms recently commented on INGN. Needham & Company LLC reaffirmed a "hold" rating on shares of Inogen in a report on Thursday, January 30th. StockNews.com upgraded Inogen from a "hold" rating to a "buy" rating in a report on Monday, February 10th.

Check Out Our Latest Stock Report on Inogen

About Inogen

(Get Free Report)

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

Further Reading

Earnings History for Inogen (NASDAQ:INGN)

Should You Invest $1,000 in Inogen Right Now?

Before you consider Inogen, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inogen wasn't on the list.

While Inogen currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines